After raising an impressive 1.2 billion euros in 2024, European venture capital firm Sofinnova Partners is topping up its ...

Strong support from pharma groups including Amgen, Bristol Myers Squibb and Pfizer has allowed European venture capital firm Sofinnova Partners to close a new biotech fund with €165 million ($180 ...

Over the last 15 years or so, as European venture capital shifted into a higher gear, one way to help a nation's ecosystem ...

Liquidity — the lifeblood of any healthy financial ecosystem — is severely lacking in the European venture ecosystem, writes ...

Amid geopolitical tensions and volatile markets, the question of Europe's ability to weather the storms ahead, especially as ...

Next up, we dive into a report from S&P Global Market Intelligence, which shows that while global private equity and venture ...

PitchBook, the premier data provider for the private and public equity markets, has released its annual US and European All ...